ESR1 and breast carcinoma: Next, we assessed whether miR-575 overexpression in breast cancer cells can influence breast cancer proliferation using stable miR-575-expressing ER+ T47D cells (T47D-miR-575) and control cells (T47D-control) generated via lentiviral infection (Figure 2A).